Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device

Abstract Background A precise approach to the diagnosis of von Willebrand disease (vWD) remains elusive. One important reason is that vWD is a blood flow‐related disorder: a vW Factor‐platelet GPIb binding defect exists in this condition under the high shear‐rate (> 1000 sec‐1 in whole blood; >...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 2012-04, Vol.129 (4), p.e18-e24
Hauptverfasser: Grabowski, Eric F, Curran, Marjorie A, Van Cott, Elizabeth M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e24
container_issue 4
container_start_page e18
container_title Thrombosis research
container_volume 129
creator Grabowski, Eric F
Curran, Marjorie A
Van Cott, Elizabeth M
description Abstract Background A precise approach to the diagnosis of von Willebrand disease (vWD) remains elusive. One important reason is that vWD is a blood flow‐related disorder: a vW Factor‐platelet GPIb binding defect exists in this condition under the high shear‐rate (> 1000 sec‐1 in whole blood; > 3000 sec‐1 in PRP) conditions of physiologic blood flow which exist in the arterioles of mucous membranes, from which most bleeding in vWD occurs. Methods We therefore studied 28 patients (mean 18.9 yrs) with vWD, diagnosed according to the 2007 NHLBI clinical guidelines, and 26 healthy controls (mean 17.5 yrs). Blood was collected into a plastic tube containing 4 U/ml FC dalteparin, 1.75 μg/ml of the Tab (anti‐CD41) monoclonal antibody directed against platelet GPIIb, and 1.0 μg/ml of an ALEXA 555‐conjugated rabbit anti‐mouse second antibody. Within 30–90 min, the blood was then withdrawn at 667 and 1330 sec − 1 through a special flow chamber allowing for real-time epifluorescence digital videomicroscopy of platelets interacting with a microfibrillar collagen substrate. With MetaMorph software (Universal Imaging) we quantified the percent area (PA) covered by and total volume (TV) of adherent platelet aggregates within a 435 μm × 580 μm field of view. Results At 667 sec − 1 after 1 min PA and TV were similar for patients and controls, but at 1330 sec − 1 PA was 9.32 ± 4.21 (mean ± SD) for patients, a value lower (p < 0.001) than the 12.8 ± 3.39 for controls. TV was (1.43 ± 0.91)x104 for patients, a value also lower (p < 0.001) than the (2.22 ± 0.77)x104 for controls. PA or TV was below the 2.5th percentile for controls in 10 patients (36%) and both PA and TV were below the 2.5th percentile in eight. Conclusions The novel flow device found that PA and TV were significantly reduced under high shear stress in vWD patients compared to normal controls. However, there was some overlap between the vWD and the control group, suggesting that some vWD patients had normal platelet adhesion/aggregation under the conditions studied. Further study with a higher shear rate appears indicated.
doi_str_mv 10.1016/j.thromres.2011.12.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_929123033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0049384811006669</els_id><sourcerecordid>929123033</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-2e624489cbd98bcb3aea9d55106e68f2ae0404568295ff8b4672fb0a99479f8d3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEokvhFSrfuJBgO44TXxBlSylSBStaxNFynEnXixMvtjfVPhZviNPtcuDCyfbo-2fG80-WnRFcEEz4200R194NHkJBMSEFoUUKP8kWpKlFTllNn2YLjJnIy4Y1J9mLEDYYk5qI6nl2QinlFa_ZIvt9HgKEMMAYkeuRQku3dv7hvvJmUN7YPVpBZ1T0RqOViiahAd2buE70KjWwG7bRTIAujLobXTBhFt_ut4AImtyIfhhrofVq7BISQAU4qr-4CSy6MndrdLMG5dE3FeFNCo-5NtGnR4c-WOc6dGndPbqAyWh4mT3rlQ3w6vE8zb5ffrxdXuXXXz99Xp5f55pRGnMKnDLWCN12oml1WypQoqsqgjnwpqcKMMOs4g0VVd83LeM17VushGC16JuuPM1eH_Juvfu1gxDlYIIGa9UIbhekoILQEpdlIvmB1N6F4KGX24fR7SXBcnZLbuTRLTm7JQmVKZyEZ48ldu0A3V_Z0Z4EvD8AkD46GfAy6DR_nfzwoKPsnPl_jXf_pNDWjEYr-xP2EDZu58c0RklkSAJ5M-_MvDKEYMw5F-UfhzjAaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>929123033</pqid></control><display><type>article</type><title>Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Grabowski, Eric F ; Curran, Marjorie A ; Van Cott, Elizabeth M</creator><creatorcontrib>Grabowski, Eric F ; Curran, Marjorie A ; Van Cott, Elizabeth M</creatorcontrib><description>Abstract Background A precise approach to the diagnosis of von Willebrand disease (vWD) remains elusive. One important reason is that vWD is a blood flow‐related disorder: a vW Factor‐platelet GPIb binding defect exists in this condition under the high shear‐rate (&gt; 1000 sec‐1 in whole blood; &gt; 3000 sec‐1 in PRP) conditions of physiologic blood flow which exist in the arterioles of mucous membranes, from which most bleeding in vWD occurs. Methods We therefore studied 28 patients (mean 18.9 yrs) with vWD, diagnosed according to the 2007 NHLBI clinical guidelines, and 26 healthy controls (mean 17.5 yrs). Blood was collected into a plastic tube containing 4 U/ml FC dalteparin, 1.75 μg/ml of the Tab (anti‐CD41) monoclonal antibody directed against platelet GPIIb, and 1.0 μg/ml of an ALEXA 555‐conjugated rabbit anti‐mouse second antibody. Within 30–90 min, the blood was then withdrawn at 667 and 1330 sec − 1 through a special flow chamber allowing for real-time epifluorescence digital videomicroscopy of platelets interacting with a microfibrillar collagen substrate. With MetaMorph software (Universal Imaging) we quantified the percent area (PA) covered by and total volume (TV) of adherent platelet aggregates within a 435 μm × 580 μm field of view. Results At 667 sec − 1 after 1 min PA and TV were similar for patients and controls, but at 1330 sec − 1 PA was 9.32 ± 4.21 (mean ± SD) for patients, a value lower (p &lt; 0.001) than the 12.8 ± 3.39 for controls. TV was (1.43 ± 0.91)x104 for patients, a value also lower (p &lt; 0.001) than the (2.22 ± 0.77)x104 for controls. PA or TV was below the 2.5th percentile for controls in 10 patients (36%) and both PA and TV were below the 2.5th percentile in eight. Conclusions The novel flow device found that PA and TV were significantly reduced under high shear stress in vWD patients compared to normal controls. However, there was some overlap between the vWD and the control group, suggesting that some vWD patients had normal platelet adhesion/aggregation under the conditions studied. Further study with a higher shear rate appears indicated.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2011.12.016</identifier><identifier>PMID: 22265674</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; bleeding score ; blood flow ; Blood Viscosity ; Child ; Child, Preschool ; Citrates ; digital videomicroscopy ; Equipment Design ; Equipment Failure Analysis ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Microscopy, Video - instrumentation ; Platelet Function Tests - instrumentation ; Reproducibility of Results ; Rheology - instrumentation ; ristocetin cofactor activity ; Sensitivity and Specificity ; shear rate ; Shear Strength ; von Willebrand disease (vWD) ; von Willebrand Disease, Type 1 - diagnosis ; von Willebrand Disease, Type 1 - physiopathology</subject><ispartof>Thrombosis research, 2012-04, Vol.129 (4), p.e18-e24</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-2e624489cbd98bcb3aea9d55106e68f2ae0404568295ff8b4672fb0a99479f8d3</citedby><cites>FETCH-LOGICAL-c422t-2e624489cbd98bcb3aea9d55106e68f2ae0404568295ff8b4672fb0a99479f8d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.thromres.2011.12.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22265674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grabowski, Eric F</creatorcontrib><creatorcontrib>Curran, Marjorie A</creatorcontrib><creatorcontrib>Van Cott, Elizabeth M</creatorcontrib><title>Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Abstract Background A precise approach to the diagnosis of von Willebrand disease (vWD) remains elusive. One important reason is that vWD is a blood flow‐related disorder: a vW Factor‐platelet GPIb binding defect exists in this condition under the high shear‐rate (&gt; 1000 sec‐1 in whole blood; &gt; 3000 sec‐1 in PRP) conditions of physiologic blood flow which exist in the arterioles of mucous membranes, from which most bleeding in vWD occurs. Methods We therefore studied 28 patients (mean 18.9 yrs) with vWD, diagnosed according to the 2007 NHLBI clinical guidelines, and 26 healthy controls (mean 17.5 yrs). Blood was collected into a plastic tube containing 4 U/ml FC dalteparin, 1.75 μg/ml of the Tab (anti‐CD41) monoclonal antibody directed against platelet GPIIb, and 1.0 μg/ml of an ALEXA 555‐conjugated rabbit anti‐mouse second antibody. Within 30–90 min, the blood was then withdrawn at 667 and 1330 sec − 1 through a special flow chamber allowing for real-time epifluorescence digital videomicroscopy of platelets interacting with a microfibrillar collagen substrate. With MetaMorph software (Universal Imaging) we quantified the percent area (PA) covered by and total volume (TV) of adherent platelet aggregates within a 435 μm × 580 μm field of view. Results At 667 sec − 1 after 1 min PA and TV were similar for patients and controls, but at 1330 sec − 1 PA was 9.32 ± 4.21 (mean ± SD) for patients, a value lower (p &lt; 0.001) than the 12.8 ± 3.39 for controls. TV was (1.43 ± 0.91)x104 for patients, a value also lower (p &lt; 0.001) than the (2.22 ± 0.77)x104 for controls. PA or TV was below the 2.5th percentile for controls in 10 patients (36%) and both PA and TV were below the 2.5th percentile in eight. Conclusions The novel flow device found that PA and TV were significantly reduced under high shear stress in vWD patients compared to normal controls. However, there was some overlap between the vWD and the control group, suggesting that some vWD patients had normal platelet adhesion/aggregation under the conditions studied. Further study with a higher shear rate appears indicated.</description><subject>Adolescent</subject><subject>Adult</subject><subject>bleeding score</subject><subject>blood flow</subject><subject>Blood Viscosity</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Citrates</subject><subject>digital videomicroscopy</subject><subject>Equipment Design</subject><subject>Equipment Failure Analysis</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Microscopy, Video - instrumentation</subject><subject>Platelet Function Tests - instrumentation</subject><subject>Reproducibility of Results</subject><subject>Rheology - instrumentation</subject><subject>ristocetin cofactor activity</subject><subject>Sensitivity and Specificity</subject><subject>shear rate</subject><subject>Shear Strength</subject><subject>von Willebrand disease (vWD)</subject><subject>von Willebrand Disease, Type 1 - diagnosis</subject><subject>von Willebrand Disease, Type 1 - physiopathology</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksFu1DAQhiMEokvhFSrfuJBgO44TXxBlSylSBStaxNFynEnXixMvtjfVPhZviNPtcuDCyfbo-2fG80-WnRFcEEz4200R194NHkJBMSEFoUUKP8kWpKlFTllNn2YLjJnIy4Y1J9mLEDYYk5qI6nl2QinlFa_ZIvt9HgKEMMAYkeuRQku3dv7hvvJmUN7YPVpBZ1T0RqOViiahAd2buE70KjWwG7bRTIAujLobXTBhFt_ut4AImtyIfhhrofVq7BISQAU4qr-4CSy6MndrdLMG5dE3FeFNCo-5NtGnR4c-WOc6dGndPbqAyWh4mT3rlQ3w6vE8zb5ffrxdXuXXXz99Xp5f55pRGnMKnDLWCN12oml1WypQoqsqgjnwpqcKMMOs4g0VVd83LeM17VushGC16JuuPM1eH_Juvfu1gxDlYIIGa9UIbhekoILQEpdlIvmB1N6F4KGX24fR7SXBcnZLbuTRLTm7JQmVKZyEZ48ldu0A3V_Z0Z4EvD8AkD46GfAy6DR_nfzwoKPsnPl_jXf_pNDWjEYr-xP2EDZu58c0RklkSAJ5M-_MvDKEYMw5F-UfhzjAaA</recordid><startdate>20120401</startdate><enddate>20120401</enddate><creator>Grabowski, Eric F</creator><creator>Curran, Marjorie A</creator><creator>Van Cott, Elizabeth M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120401</creationdate><title>Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device</title><author>Grabowski, Eric F ; Curran, Marjorie A ; Van Cott, Elizabeth M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-2e624489cbd98bcb3aea9d55106e68f2ae0404568295ff8b4672fb0a99479f8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>bleeding score</topic><topic>blood flow</topic><topic>Blood Viscosity</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Citrates</topic><topic>digital videomicroscopy</topic><topic>Equipment Design</topic><topic>Equipment Failure Analysis</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Microscopy, Video - instrumentation</topic><topic>Platelet Function Tests - instrumentation</topic><topic>Reproducibility of Results</topic><topic>Rheology - instrumentation</topic><topic>ristocetin cofactor activity</topic><topic>Sensitivity and Specificity</topic><topic>shear rate</topic><topic>Shear Strength</topic><topic>von Willebrand disease (vWD)</topic><topic>von Willebrand Disease, Type 1 - diagnosis</topic><topic>von Willebrand Disease, Type 1 - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grabowski, Eric F</creatorcontrib><creatorcontrib>Curran, Marjorie A</creatorcontrib><creatorcontrib>Van Cott, Elizabeth M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grabowski, Eric F</au><au>Curran, Marjorie A</au><au>Van Cott, Elizabeth M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2012-04-01</date><risdate>2012</risdate><volume>129</volume><issue>4</issue><spage>e18</spage><epage>e24</epage><pages>e18-e24</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Abstract Background A precise approach to the diagnosis of von Willebrand disease (vWD) remains elusive. One important reason is that vWD is a blood flow‐related disorder: a vW Factor‐platelet GPIb binding defect exists in this condition under the high shear‐rate (&gt; 1000 sec‐1 in whole blood; &gt; 3000 sec‐1 in PRP) conditions of physiologic blood flow which exist in the arterioles of mucous membranes, from which most bleeding in vWD occurs. Methods We therefore studied 28 patients (mean 18.9 yrs) with vWD, diagnosed according to the 2007 NHLBI clinical guidelines, and 26 healthy controls (mean 17.5 yrs). Blood was collected into a plastic tube containing 4 U/ml FC dalteparin, 1.75 μg/ml of the Tab (anti‐CD41) monoclonal antibody directed against platelet GPIIb, and 1.0 μg/ml of an ALEXA 555‐conjugated rabbit anti‐mouse second antibody. Within 30–90 min, the blood was then withdrawn at 667 and 1330 sec − 1 through a special flow chamber allowing for real-time epifluorescence digital videomicroscopy of platelets interacting with a microfibrillar collagen substrate. With MetaMorph software (Universal Imaging) we quantified the percent area (PA) covered by and total volume (TV) of adherent platelet aggregates within a 435 μm × 580 μm field of view. Results At 667 sec − 1 after 1 min PA and TV were similar for patients and controls, but at 1330 sec − 1 PA was 9.32 ± 4.21 (mean ± SD) for patients, a value lower (p &lt; 0.001) than the 12.8 ± 3.39 for controls. TV was (1.43 ± 0.91)x104 for patients, a value also lower (p &lt; 0.001) than the (2.22 ± 0.77)x104 for controls. PA or TV was below the 2.5th percentile for controls in 10 patients (36%) and both PA and TV were below the 2.5th percentile in eight. Conclusions The novel flow device found that PA and TV were significantly reduced under high shear stress in vWD patients compared to normal controls. However, there was some overlap between the vWD and the control group, suggesting that some vWD patients had normal platelet adhesion/aggregation under the conditions studied. Further study with a higher shear rate appears indicated.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>22265674</pmid><doi>10.1016/j.thromres.2011.12.016</doi></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2012-04, Vol.129 (4), p.e18-e24
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_929123033
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Adult
bleeding score
blood flow
Blood Viscosity
Child
Child, Preschool
Citrates
digital videomicroscopy
Equipment Design
Equipment Failure Analysis
Hematology, Oncology and Palliative Medicine
Humans
Male
Microscopy, Video - instrumentation
Platelet Function Tests - instrumentation
Reproducibility of Results
Rheology - instrumentation
ristocetin cofactor activity
Sensitivity and Specificity
shear rate
Shear Strength
von Willebrand disease (vWD)
von Willebrand Disease, Type 1 - diagnosis
von Willebrand Disease, Type 1 - physiopathology
title Assessment of a Cohort of Primarily Pediatric Patients with a Presumptive Diagnosis of Type 1 von Willebrand Disease with a Novel High Shear Rate, Non-citrated Blood Flow Device
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A17%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20a%20Cohort%20of%20Primarily%20Pediatric%20Patients%20with%20a%20Presumptive%20Diagnosis%20of%20Type%201%20von%20Willebrand%20Disease%20with%20a%20Novel%20High%20Shear%20Rate,%20Non-citrated%20Blood%20Flow%20Device&rft.jtitle=Thrombosis%20research&rft.au=Grabowski,%20Eric%20F&rft.date=2012-04-01&rft.volume=129&rft.issue=4&rft.spage=e18&rft.epage=e24&rft.pages=e18-e24&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2011.12.016&rft_dat=%3Cproquest_cross%3E929123033%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=929123033&rft_id=info:pmid/22265674&rft_els_id=1_s2_0_S0049384811006669&rfr_iscdi=true